Research Type: Business and Popular Press

Our expertise and opinions regarding drug pricing and development are sought by journalists for both Business and Popular Press. Our editorial writings, often in collaboration with other experts, allows us to comment in a broader forum.

Medicare Must Study Unproven, Expensive Alzheimer’s Drug
Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle
We can’t tackle the pandemic without figuring out which Covid-19 vaccines work the best
Instead of debating ‘first-shot’ vs ‘set-aside’ vaccine approaches, hospitals’ study should compare them
After 4 Years of Trump, Medicare and Medicaid Badly Need Attention
The Science on Coronavirus is Topsy-Turvy. That’s Fine.
The Drugs at the Heart of Our Pricing Crisis
COVID-19 Reduced Average Life Expectancy of Americans by Five Days, Not One Year
COVID-19 Urgency for a Vaccine Demands Patience
Drop in Cancer Deaths Reflect Failures of Our Society. Really.

Research Type: Business and Popular Press

Medicare Must Study Unproven, Expensive Alzheimer’s Drug

Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle

We can’t tackle the pandemic without figuring out which Covid-19 vaccines work the best

Instead of debating ‘first-shot’ vs ‘set-aside’ vaccine approaches, hospitals’ study should compare them

After 4 Years of Trump, Medicare and Medicaid Badly Need Attention

The Science on Coronavirus is Topsy-Turvy. That’s Fine.

The Drugs at the Heart of Our Pricing Crisis

COVID-19 Reduced Average Life Expectancy of Americans by Five Days, Not One Year

COVID-19 Urgency for a Vaccine Demands Patience

Drop in Cancer Deaths Reflect Failures of Our Society. Really.